COST OF TREATMENT WITH BIOSIMILARS - CASE WITH RITUXIMAB IN ONCOHEMATOLOGY

被引：0
|
作者：
Boncheva, E. [1 ]
Cherneva, D. [2 ]
Benisheva, T. [1 ]
机构：
[1] Med Univ Sofia, Sofia, Bulgaria
[2] Bulgarian Assoc Drug Informat, Sofia, Bulgaria
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSC209
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [31] Biosimilars: it's not as simple as cost alone
    Roger, S. D.
    Goldsmith, D.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (05) : 459 - 464
  • [32] COST CONSEQUENCE ANALYSIS OF RITUXIMAB TREATMENT FOR RHEUMATOID ARTHRITIS IN ISRAEL
    Hammerman, A.
    Klang, S. H.
    Liebermann, N.
    Birenboim-Gal, T.
    Shuali, A.
    Kfir, M.
    VALUE IN HEALTH, 2008, 11 (06) : A544 - A545
  • [33] Biosimilars for the treatment of psoriasis
    Puig, Lluis
    Lopez-Ferrer, Anna
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (10) : 993 - 1000
  • [34] COST-EFFECTIVENESS OF RITUXIMAB IN THE TREATMENT OF RA PATIENTS IN THE NETHERLANDS
    Diamantopoulos, A.
    Kievit, W.
    De Vries, R.
    Pompen, M.
    VALUE IN HEALTH, 2011, 14 (07) : A311 - A311
  • [35] Rituximab in treatment of collapsingFSGS-A case series
    Girimaji, Niveditha
    Bharati, Joyita
    Nada, Ritambhra
    Rathi, Manish
    Kohli, Harbir Singh
    Ramachandran, Raja
    NEPHROLOGY, 2021, 26 (02) : 134 - 141
  • [36] Treatment with Rituximab in Rheumatoid Pneumoconiosis: A Case Report
    Yasmine, Makhlouf
    Kaouther, Maatallah
    Dhia, Kaffel
    Hanene, Ferjani
    Wafa, Triki
    Dorra, Ben Nessib
    Wafa, Hamdi
    CURRENT DRUG SAFETY, 2023, 18 (03) : 383 - 385
  • [37] Treatment of lupus nephritis with rituximab: a case report
    Pinto, H.
    Brito, I.
    Afonso, C.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1651 - 1651
  • [38] Cost-Effectiveness of Obinutuzumab Plus Chemotherapy Versus Rituximab Biosimilars Plus Chemotherapy for Patients with Previously Untreated Follicular Lymphoma
    Veenstra, David L.
    Guzauskas, Gregory F.
    Spencer, Scott J.
    Felizzi, Federico
    Launonen, Aino
    Dawson, Keith
    Masaquel, Anthony
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S280 - S280
  • [39] Clinical and fringe benefits of rituximab in multiple sclerosis treatment in a poor resource setting: Case series and cost analysis
    Aungsumart, Saharat
    Apiwattanakul, Metha
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 73
  • [40] Fidaxomicin in the treatment of Clostridium difficile infection in oncohematology patients
    Martin Rizo, Lara
    Malpartida Flores, Maria
    Fernandez Lison, Luis Carlos
    MEDICINA CLINICA, 2019, 153 (07): : 298 - 299
12345